Irene Ferrer

3.5k total citations · 1 hit paper
66 papers, 2.3k citations indexed

About

Irene Ferrer is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Irene Ferrer has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Irene Ferrer's work include Lung Cancer Treatments and Mutations (16 papers), Cancer-related Molecular Pathways (7 papers) and Fibroblast Growth Factor Research (6 papers). Irene Ferrer is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Cancer-related Molecular Pathways (7 papers) and Fibroblast Growth Factor Research (6 papers). Irene Ferrer collaborates with scholars based in Spain, United States and France. Irene Ferrer's co-authors include Luis Paz‐Ares, Jon Zugazagoitia, Sonia Molina‐Pinelo, Santiago Ponce, Amancio Carnero, Stephan Herbertz, Gerald Schmid‐Bindert, William J. John, Àlvaro Quintanal-Villalonga and Carmen Blanco‐Aparicio and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Irene Ferrer

63 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current Challenges in Cancer Treatment

2016 656 citations Jon Zugazagoitia, Irene Ferrer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irene Ferrer Spain	25	1.2k	769	472	409	238	66	2.3k
Yuan Chen China	27	1.2k 1.0×	516 0.7×	534 1.1×	329 0.8×	310 1.3×	121	2.4k
Susanne Fuessel Germany	29	1.4k 1.2×	559 0.7×	644 1.4×	611 1.5×	257 1.1×	91	2.5k
Anca Maria Cîmpean Romania	24	1.2k 1.0×	1.0k 1.3×	563 1.2×	395 1.0×	388 1.6×	180	2.9k
Chia‐Ling Hsieh Taiwan	31	1.4k 1.1×	659 0.9×	484 1.0×	404 1.0×	355 1.5×	86	2.5k
Debabrata Saha United States	29	1.1k 0.9×	676 0.9×	471 1.0×	576 1.4×	179 0.8×	111	2.4k
Darran P. O’Connor Ireland	29	1.5k 1.3×	707 0.9×	739 1.6×	250 0.6×	184 0.8×	80	2.7k
Yu‐Chan Chang Taiwan	30	1.3k 1.1×	405 0.5×	842 1.8×	305 0.7×	253 1.1×	109	2.5k
Jiang Yang United States	19	1.3k 1.1×	708 0.9×	678 1.4×	244 0.6×	336 1.4×	45	2.7k
Shi‐Long Lu United States	29	1.8k 1.5×	1.1k 1.5×	669 1.4×	320 0.8×	247 1.0×	63	3.3k
Michael H. Muders Germany	30	1.3k 1.0×	904 1.2×	502 1.1×	554 1.4×	178 0.7×	79	2.7k

Countries citing papers authored by Irene Ferrer

Since Specialization

Citations

This map shows the geographic impact of Irene Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Ferrer more than expected).

Fields of papers citing papers by Irene Ferrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Ferrer. The network helps show where Irene Ferrer may publish in the future.

Co-authorship network of co-authors of Irene Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Ferrer. A scholar is included among the top collaborators of Irene Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Ferrer. Irene Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Álvarez-Pérez, Juan Carlos, Álvaro Andrades, Silvia Calabuig‐Fariñas, et al.. (2025). High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models. Nature Communications. 16(1). 7080–7080.

Jiménez-Reinoso, Anaïs, Cristina Cirauqui, Belén Blanco, et al.. (2024). CD4 ⁺ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. OncoImmunology. 13(1). 2392897–2392897. 5 indexed citations

Ferrer, Irene, et al.. (2021). Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma. International Journal of Molecular Sciences. 22(5). 2538–2538. 5 indexed citations

Quintanal-Villalonga, Àlvaro, Irene Ferrer, Elizabeth Guruceaga, et al.. (2020). FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy. EBioMedicine. 53. 102683–102683. 17 indexed citations

Romaniello, Donatella, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.. (2020). Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor. Cancers. 12(9). 2394–2394. 40 indexed citations

Márquez, César, Kaja Kostyrko, Amanda Koehne, et al.. (2019). Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma. Nature Medicine. 25(11). 1783–1795. 51 indexed citations

Ferrer, Irene, María Dolores Pastor, Àlvaro Quintanal-Villalonga, et al.. (2019). Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry. Cells. 8(8). 806–806. 3 indexed citations

Ferrer, Irene, Jon Zugazagoitia, Stephan Herbertz, et al.. (2018). KRAS-Mutant non-small cell lung cancer: From biology to therapy. Lung Cancer. 124. 53–64. 229 indexed citations

Verdugo‐Sivianes, Eva M., Lola E. Navas, Sonia Molina‐Pinelo, et al.. (2017). Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer. Oncotarget. 8(62). 105196–105210. 16 indexed citations

10.

Zugazagoitia, Jon, Daniel Rueda, Ana B. Enguita, et al.. (2017). Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non–Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments. Clinical Lung Cancer. 19(1). 65–73.e7. 8 indexed citations

11.

Paz‐Ares, Luis, et al.. (2016). Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer. Disease Markers. 2016. 1–12. 27 indexed citations

12.

Quintanal-Villalonga, Àlvaro, Luis Paz‐Ares, Irene Ferrer, & Sonia Molina‐Pinelo. (2016). Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications. Disease Markers. 2016. 1–14. 11 indexed citations

13.

Molina‐Pinelo, Sonia, Gabriel Gutiérrez, María Dolores Pastor, et al.. (2014). MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer. PLoS ONE. 9(3). e90524–e90524. 66 indexed citations

14.

Palafox, Marta, Irene Ferrer, Pasquale Pellegrini, et al.. (2012). RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis. Cancer Research. 72(11). 2879–2888. 153 indexed citations

15.

Molina‐Pinelo, Sonia, Irene Ferrer, Carmen Blanco‐Aparicio, et al.. (2011). Down‐regulation of spinophilin in lung tumours contributes to tumourigenesis. The Journal of Pathology. 225(1). 73–82. 19 indexed citations

16.

Blanco‐Aparicio, Carmen, et al.. (2010). Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models. PLoS ONE. 5(2). e9305–e9305. 21 indexed citations

17.

Reñé, R., et al.. (2009). Familial Creutzfeldt–Jakob disease with E200K mutation presenting with neurosensorial hypoacusis: Figure 1. BMJ Case Reports. 2009. bcr0620092006–bcr0620092006. 1 indexed citations

18.

Martínez-Leal, Juan Fernando, Irene Ferrer, Carmen Blanco‐Aparicio, et al.. (2008). S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis. Carcinogenesis. 29(11). 2089–2095. 57 indexed citations

19.

Ferrer, Irene, et al.. (2007). Síntesis, configuración y conformación de algunas &-lactonas y 3,4-dihidro-2-piridonas ópticamente activas. Afinidad. 64(528). 207–215. 1 indexed citations

20.

Castro, Elena, Irene Ferrer, Alberto Cascón, et al.. (2007). PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis. 29(3). 491–499. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact